GGI
AGTC

Godsey & Gibb Inc’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Godsey & Gibb Inc’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-500
Closed -$2K – 154
2021
Q3 		$2K Hold
500
– – ﹤0.01% 87
2021
Q2 		$2K Buy
+500
New +$2.07K ﹤0.01% 88

Other funds holding AGTC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Godsey & Gibb Inc's AGTC Position: Q4 2021 in Review

Godsey & Gibb Inc sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2021, closing a stake of 500 shares — an estimated $2K sold.

Godsey & Gibb Inc first reported a position in AGTC in Q2 2021 and held it in 2 quarters. The position peaked at $2K in Q3 2021. 55 funds tracked by Wall St. Rank hold AGTC as of Q4 2021.

  • Godsey & Gibb Inc reported no remaining Applied Genetic Technologies Corporation position as of Q4 2021 after selling out during the quarter.
  • Godsey & Gibb Inc sold 500 Applied Genetic Technologies Corporation shares in Q4 2021, an estimated $2K.
  • Godsey & Gibb Inc first reported a position in Applied Genetic Technologies Corporation in Q2 2021 and held it in 2 quarters.
  • Godsey & Gibb Inc's Applied Genetic Technologies Corporation position peaked at $2K in Q3 2021.
  • 55 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2021.

Based on Godsey & Gibb Inc's 13F filing for Q4 2021, filed 15 Feb 2022.